Since retiring from P&G, Jeff launched Weedman Ventures, LLC, to consult with business professionals and startups.
Jeff is currently the CEO/ Co-Founder of Sus Clinicals. A biotech company with the expertise to help healthcare partners significantly reduce the time and expense of qualifying new cancer-fighting drugs, medical devices, and diagnostics for human clinical trials, via an FDA-cleared innovative pre-clinical model.
At P&G, Jeff held senior executive roles in Marketing, Sales, Finance, and General Management running consumer and institutional businesses in the U.S. and Canada. Jeff then founded and led P&G’s Global Business Development–responsible for worldwide Acquisitions/Divestitures/ Joint Ventures, in/outbound Trademark/Patent Licensing, and leading P&G’s Open Innovation Platform (Connect & Develop). Jeff negotiated and led the signing of deals (every 2.5 days for a decade) with companies, individuals, Universities, and Governments across the U.S., Europe, and Asia. Jeff retired as Vice President of Global Business Development.
As Co-Founder/CEO of Cintrifuse, Jeff led the development/creation of Cintrifuse, a Cincinnati-based innovation network designed to make the region a global destination for high-potential start-ups. Cintrifuse provides start-ups with preferred access to capital, space, and, most importantly, connections. Supported by the business, academic, and start-up communities, Cintrifuse initially raised a $55MM+ Fund of Funds, which invested in top-tier Venture firms with over $600MM in investable capital. He also secured a $16MM permanent mortgage-free urban campus (circa 1880s) in Cincinnati’s urban renewal Over-The-Rhine core. Cintrifuse continues to proactively connect startups with companies that could be beta customers, investors, or acquirers, with V.C.s with early-stage capital and mentors/services.
.